Self-Host
Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
Benitec Biopharma Inc. (BNTC) Insider Trading Activity
Healthcare • Biotechnology • 16 employees
Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference-based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy. Benitec Biopharma Inc. was incorporated in 1995 and is headquartered in Hayward, California.
Total Value
$1,546,988.56
Total Shares
182,769
Average Trade Value
$140,635.32
Most Active Insider
Suvretta Capital Management, Llc
Total Activity: $1,346,990
Largest Single Transaction
$357,024
by Suvretta Capital Management, Llc on Dec 3, 2024
30-Day Activity
0 Transactions
Volume: 0 shares
Value: $0
|
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
|---|---|---|---|---|---|---|
|
Director
|
Feb 27, 2025 | 51,813 | $199,998 | 103,910 (+49.9%) | Exercise/Conversion | |
| Dec 24, 2024 | 17,730 | $199,463 | 7,999,455 (+0.2%) | Purchase | ||
| Dec 24, 2024 | 2,288 | $25,740 | 960,554 (+0.2%) | Purchase | ||
| Dec 23, 2024 | 3,142 | $34,499 | 958,266 (+0.3%) | Purchase | ||
| Dec 23, 2024 | 24,360 | $267,473 | 7,981,725 (+0.3%) | Purchase | ||
| Dec 3, 2024 | 4,810 | $46,176 | 955,124 (+0.5%) | Purchase | ||
| Dec 3, 2024 | 37,190 | $357,024 | 7,957,365 (+0.5%) | Purchase | ||
| Nov 20, 2024 | 3,076 | $31,437 | 950,314 (+0.3%) | Purchase | ||
| Nov 20, 2024 | 24,360 | $248,959 | 7,920,175 (+0.3%) | Purchase | ||
| Nov 19, 2024 | 12,430 | $120,944 | 7,895,815 (+0.2%) | Purchase | ||
| Nov 19, 2024 | 1,570 | $15,276 | 947,238 (+0.2%) | Purchase |